Gyroscope spins the wheel again as it taps Sanofi for $60M months after ditching IPO attempt

[cafead]

via The biotech IPO window, at the start of the year at least, was wide open, leaving more than a few people scratching their heads when eye disease biotech Gyroscope Therapeutics said back in May it was ditching its plans because of “market conditions.”

article source